Marketresearchnews

Tuesday, 23 March 2021

Mastitis Market Revenue and Value Chain 2020-2027

The Global Mastitis Market is expected to register a CAGR of 15.07% to reach USD 18,338.80 Million till 2023. Mastitis is an infection in the tissue of one or both mammary glands inside the breast. It usually affects women who are breastfeeding, and it results from a blocked or a plugged duct. In bovine, mastitis is the inflammation of the mammary gland and udder tissue due to bacterial invasion of the teat canal by a variety of bacterial sources present on the farm, and can also occur as a result of chemical, mechanical, or thermal injury to the cow’s udder.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5379

The rising cases of breast cancer, increasing rate of pregnancy, and unhygienic barn conditions causing contagious mastitis in bovines across the globe is expected to enhance the market growth. However, the lack of awareness and complications in diagnosis due to similar symptoms of breast cancer & mastitis are projected to curb the growth of the market.

Market Dynamics

Mastitis has been gaining significance in recent years, owing to the rising incidence of breast cancer. For instance, the Breast Cancer Research Foundation estimated that 266,120 new cases of invasive breast cancer were diagnosed in women in 2018 in the US. Similarly, the UK witnessed around 11,563 deaths due to breast cancer in 2016, according to the Cancer Research UK. Whereas, according to the World Cancer Research Fund International, Belgium had the highest rate of breast cancer in women in 2017. Such a vast population suffering from breast cancer boosts market growth during the forecast period.

Segmentation

The global mastitis market, by type, has been segmented into bovine and human. Based on treatment, the Mastitis market has been categorized as bovine and human. Based on end user, the mastitis market has been classified as veterinary centers and hospital & clinics.

Regional Analysis

The global mastitis market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to hold the largest share of the global mastitis market. North America is expected to dominate the market, mainly due to the increasing p prevalence of mastitis among the bovine population and increasing incidence of breast cancer in the region.

Europe is expected to account for the second-largest market share during the forecast period. The factors responsible for market growth in this region are advanced treatment facilities, rising government initiatives to promote healthy breastfeeding, and growing healthcare expenditure. For instance, according to Eurostat, Germany spent over EUR 321 billion in 2014.

Asia-Pacific is estimated to be the fastest-growing region in the global market due to the presence of rapidly developing economies such as China, India, and South Korea. Moreover, the vast patient pool of chronic diseases and government initiatives of healthcare reforms will support the growth of the market.

The mastitis market in the Middle East & Africa is expected to grow due to the affordability and accessibility of healthcare.

Key Players

The prominent players in the global Mastitis market are Bayer AG (Germany), Oncothyreon Inc (US), OncoGenex (US), Apthera Inc. (UK), Zoetis Inc. (US), Boehringer Ingelheim GmbH (Germany), Merck Co. & Inc. (US), Astellas Pharma Inc. (Japan), Pfizer Inc. (US), Novartis AG (Switzerland), Sanofi SA (France), and F. Hoffmann-La Roche AG (Switzerland).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mastitis-market-5379

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Egg Allergy Market Forecast to 2027 – Driven by Industry Major Players, Dynamics, Future Opportunities, Revenue, Growth

The Global Egg Allergy Market is expected to register a CAGR of 7.10%and is anticipated to reach USD 2304.3 Million by 2023. Egg allergies are the most common food allergies. Symptoms of egg allergy can occur immediately or within a few minutes or a few hours. Egg allergy can affect infants as well as adults. The adverse effects of egg allergy can vary from hives or rashes to a severe allergic reaction known as anaphylaxis. Egg allergy happens when there is an overreaction to eggs by the immune system. The immune system identifies egg proteins as harmful and triggers an allergic reaction.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4734

The increasing prevalence of egg allergy and improved allergy diagnosis are the major drivers propelling market growth. However, the lack of awareness in developing countries and high cost constrain the growth of the market.

Market Dynamics

The continued growth in several egg allergy patients is responsible for the increasing demand for required diagnostic tests and medication such as epinephrine autoinjectors, and ultimately, it is propelling the growth of the market. For instance, according to the report published by, McGill University in 2016, egg allergy is common in infants and young children and affects 1 to 2% of the preschool children. Additionally, improved allergy diagnosis is likely to support market growth. On the other hand, the lack of awareness in developing countries and high cost is anticipated to hamper the market growth.

Segmentation

The global egg allergy market has been segmented into age type, diagnosis & treatment, and end user. By age type, the market has been segmented into children and adults. The global egg allergy market has two primary sides—diagnosis & treatment. The global egg allergy market, by diagnosis, has been segmented into skin test, blood test, food challenge, and others. The global egg allergy market, by treatment, has been segmented into medication and oral immunotherapy. By end-user, the market has been segmented into hospitals and clinics, diagnostic centers, research institutes, and others. The hospitals and clinics segment accounted for a market value of USD 729.2 million in 2017.

Key Players

The prominent players in the global egg allergy market are Sanofi SA (France), Genentech, Inc. (the US), Quest Diagnostics (US), ImmuneTech (US), HYCOR Biomedical (US), Kaleo, Inc. (the US), Alletess Medical Laboratory (US), Creative Diagnostics (US), Imutest Ltd (UK), Mylan NV (US), and Impax Laboratories (US).

Some of the key strategies followed by the players operating in the global egg allergy market were innovation, product development, acquisition, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/egg-allergy-market-4734

About Us:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Tissue Microarray Market 2020 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast By 2027

The Global Tissue Microarray Market is expected to register a CAGR of 10.54% and is anticipated to reach USD 10,914.54 million by 2023. Tissue microarrays are paraffin blocks that are created by separating cylindrical tissue cores from different paraffin donor blocks and re-embedding these into a microarray at defined array coordinates. With the help of tissue microarray, up to at least 1000 tissue samples can be arrayed into a single paraffin piece. It allows simultaneous analysis of molecules present in DNA, mRNA, and protein levels under identical, standardized conditions on a single glass slide. This adaptable strategy, in which data analysis is automated, facilitates retrospective and prospective human tissue studies.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1213

The increasing application in drug discovery, increasing prevalence of cancer, growing advancements in biotechnology and pharmaceutical companies, and rising demand for cost-effective and accurate diagnostic methods are the major drivers propelling market growth. However, tissue microarray may not be fruitful for heterogeneous cancers, which is likely to constrain the growth of the market.

Market Dynamics

The prevalence of cancer is one of the crucial factors that drive the growth of the tissue microarray market. According to the American Cancer Society, in 2017, nearly 13% of all cancers diagnosed in adults aged 20. It further stated that rates of liver cancer, thyroid cancer, and melanoma are increasing from last few years. According to US Breast Cancer Statistics, about 1 in 8 US women (about 12%) will develop invasive breast cancer throughout their lifetime. In 2017, an estimated 252,710 new cases of invasive breast cancer were expected to be diagnosed in women in the US, along with 63,410 new cases of non-invasive (in-situ) breast cancer.

Moreover, increasing advancements in biotechnology and pharmaceutical companies and growing demand for cost-effective and accurate diagnostic methods have fueled the growth of the market. On the other hand, tissue microarray is that it may not be fruitful for heterogeneous cancers anticipated to hamper the market growth.

Segmentation

The global tissue microarray market has been divided into the procedure, technology, application, and end user. By procedure, the market has been segregated into immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array. Based on technology, the market has been segmented into DNA microarray, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, and western blotting. Based on the application, the market has been bifurcated into oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, comparative genomic hybridization, and sequencing bioinformatics. By end-user, the market has been classified as pharmaceutical and biotechnological companies and research organization. The research organization segment accounted for a market value of USD 1876.02 million in 2016.

Key Players

The prominent players in the global tissue microarray market are Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, QIAGEN, Takara Bio, Perkin Elmer, and Merck Sharp & Dohme Corp.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/tissue-microarray-market-1213

About Us:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Bone Densitometers Market Revenue and Value Chain 2020-2027

Market Scenario:

Bone densitometry is a type of non-invasive technology which is used to measure bone mass. This technology measures the amount of loss of bone mass in a patient’s body. Bone mass is the weight of the skeleton, overall or in specific regions. Nowadays, bone densitometry is used as an established standard to measure the bone material density. The market for bone densitometer is growing at a comparatively good rate. Growing senior population which are highly susceptible to bone related diseases has fueled the growth of bone densitometer market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2300

The global market for bone densitometers is expected to reach around USD 1.2 billion by the end of the forecast period and is expected to grow at a CAGR of ~5.3%.

Study Objectives Global Bone Densitometers Market:

To provide detail analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global Bone Densitometers market
To provide insights about factors affecting the market growth
To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future prospective
To provide country level analysis of the market for segments by type, by technology, by end users and other sub segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

Key Players for Global Bone Densitometers Market:

Some of the key players in this market are: General Electric Company, Hologic, Inc., Swissray, Osteosys Co. Ltd, MedWrench, LLC, Schick Sirona, DMS Imaging, Echolight S.p.a., Aarna Systems And Wellness Pvt. Ltd., Tecnicare Healthcare Company and others.

Segments:

Global Bone Densitometers market has been segmented on the basis of type which comprises central scanners, peripheral scanners and others. On the basis of technology; market is segmented into quantitative computed tomography (QCT), radiographic absorptiometry (RA), single x-ray absorptiometry (SXA), dual-energy x-ray absorptiometry (DXA) and others. On the basis of end users; market is segmented hospitals, orthopedic clinics, academic & research institutes and others.

Regional Analysis of Global Bone Densitometers Market:

Globally America is the largest market for bone densitometers. The American market for bone densitometers is expected to reach around USD 650 million by the end of the forecast period of 2016-2022. Europe is the second-largest market for bone densitometers. Asia pacific region is expected to be fastest growing region in bone densitometers market.

The report for Global Bone Densitometers Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/bone-densitometers-market-2300

Cataract Surgery device Market: Recent Industry Trends and Projected Industry Growth, 2020– 2027

The globally market for cataract surgery device is growing steadily. Factors that influence the cataract surgery device market are increasing prevalence of cataract surgery, increasing advance technology in cataract surgery device market, increase in the aging population, prevalence of eye disease and many others. Globally the market for cataract surgery device is expected to grow at the rate of about 5.5% from 2016 to 2022.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2115

Key Finding

The cataract surgery device global market is expected to reach $4.5 billion by 2022.
Intraocular lens (IOL) holds the largest share of 79% of the cataract surgery device market.
North America holds the largest market share of around 46% of cataract surgery device.
Asia Pacific is expected to be the fastest growing market at a CAGR of 5.5%

Key Players for Cataract Surgery device Market:
Some of the key players in this market are: Alcon, Inc. (U.S), Abbott Laboratories (U.S.), Carl Zeiss Meditech AG (Germany), Essilor International S.A. (France), Opcon Corporation (Japan), Allergan, Inc. (U.S.), Bausch & Lomb, Inc. (U.S.), NIDEK Co., Ltd. (Japan), STAAR Surgical Company (U.S.) and others.

Intended Audience

Cataract Surgery device manufacturers & suppliers
Biotechnology companies
Hospitals
clinics
Academic research institutes
Government institutes

Market Segments:
Global Cataract Surgery device market has been segmented on the basis of device type which comprises of intraocular lens (IOL), ophthalmic viscoelastic device (OVD), phacoemulsification equipment and femtosecond laser equipment.
Furthermore on the basis of end user the market is segmented into ophthalmology centers, hospitals, clinics and others.

Study objectives of the Market:

Providing detail analysis of the market structure along with forecast for the next 7 years of various segments and sub-segments of the Cataract Surgery device market.
Giving insights about factors affecting the market growth.
Analyzing the market based on various factors- price analysis, supply chain analysis, Porters Five Force analysis etc.
Giving the past revenue and predicted future revenue of the market segments and sub-segments with respect to the main market and various markets globally.
Giving regional level analysis of the market with respect to the current market size and future prospective.
Giving regional level analysis of the market with respect to segments, device type, end-users and market’s sub-segments.
Providing an overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive structure of the market.
Tracking and analyzing competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments in the global Cataract Surgery device market.

Regional Analysis of Cataract Surgery device Market:
Globally North America is the largest market for Cataract Surgery device market. The North American market for Cataract Surgery device is expected to grow at a CAGR of 4.9%. Europe is the second-largest market for Cataract Surgery device which is expected to grow at a CAGR of 5.2%. Asia pacific region is expected to be fastest growing region in Cataract Surgery device market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cataract-surgery-device-market-2115

Research report covers the Clinical Trial Management System Market Forecasts and Growth, 2020-2027

Clinical Trial Management System (CTMS) Market is expected to grow significantly over the forecast period. The market held a valuation of USD 732.5 Million in 2018 and is projected to account for USD 1,631.3 Million by 2025, registering a CAGR of 12.0% over the forecast period.

The rising frequency of long-lasting diseases and the rapid growth rate of healthcare service benefactors are likely to drive for the growth of the market during the forecast period.

Various other factors, such as the low battery life of mobile computers and reimbursement policies, are also expected to propel the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2054

However, growing clinical trial failure rates and lengthy clinical trial approval time can impede the market growth over the forecast period.

Segmentation

The Global Clinical Trial Management System Market has been segmented based on type, delivery model, component, end user, and region.

The global market for clinical trial management system, by type, has been segmented into enterprise CTMS and on-site CTMS.

The delivery model segment consists of web-based (hosted CTMS), licensed enterprise, and cloud-based CTMS (SaaS).

On the basis of component, the market has been segmented into software, service, and hardware.

The end users of the market have been segmented into pharmaceutical and biopharmaceutical companies, medical device manufacturers, contract research organizations, and others.

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The clinical trial management system market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European clinical trial management system market has been segmented into Western Europe and Eastern Europe. Western Europe has been segmented into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The clinical trial management system market in Asia-Pacific has been classified as Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The clinical trial management system market in the Middle East & Africa has been divided into the Middle East and Africa.

Regional Market Summary

The Americas dominated the global market for a clinical trial management system owing to the increasing investments in research and development of CTMS by major companies and government organizations. In 2019, according to ClinicalTrials.gov database, there were total 322,282 studies registered for clinical trials, wherein and 34% cases registered from the US and 49% from other countries.

In 2018, Europe stood second in the global clinical trial management system market. The growing healthcare IT sector and high accuracy level of information provided by the clinical trial management system is expected to drive the growth of the market. Germany is expected to have the largest share in the European market for clinical trial management systems.

Asia-Pacific is expected to register the fastest growth in clinical trial management system market throughout the forecast period due to the growing customer base for CTMS solutions, growing demand for CMTS in the key markets around the globe, and the favorable government policies for the growth of healthcare IT sector in the region. The increasing sedentary lifestyle is countries in Asia-Pacific fuels the market growth in this region. Moreover, the presence of countries such as China, India, and Japan is expected to have positive impact on the market growth.

On the other hand, the Middle East and Africa held the least share in the global clinical trial management system market due to the lack of awareness and low income, especially within Africa.

Key Players

Some of the key players in the Global Clinical Trial Management System Market are Forte Research Systems Inc., eClinForce, Inc., Oracle, Medidata Solutions, iWeb Technologies, PAREXEL, Bioclinica, Bio-Optronics, IBM, Datatrak, Veeva Systems, DSG, Mastercontrol, ERT, Mednet Solutions, Arisglobal, DZS Software Solutions, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/clinical-trial-management-system-market-2054

Monday, 22 March 2021

Avian Influenza Vaccine Market – Revolutionary Trends 2027

Global Avian Influenza Vaccine Market is expected to register a CAGR of 7.25% to reach USD 735.22 Million by 2025. Avian influenza, also known as bird flu, is a viral infection that spreads from bird to bird and can infect other animals or humans also. There are different strains of avian influenza, causing the infection, but H5V1 is the most common virus strain affecting poultry animals.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8769

Market Dynamics

The increasing strategic agreements are expected to drive market growth during the study period. For instance, in February 2018, the NC State College of Veterinary Medicine and Ceva Santé Animale, an animal health company, based in France, collaborated on a distance learning project providing certification in poultry health management for veterinarians in Latin America. Moreover, the increasing public & private initiatives by the government as well as non-government organizations for research & development are also anticipated to drive the market growth.

Segmentation

The Global Avian Influenza Vaccine Market has been segmented by strain and application. The market, based on strain, has been bifurcated into H5, H7, and H9. Based on application, the avian influenza vaccine market has been chicken, turkey, and goose & duck.

Regional Analysis

The Global Avian Influenza Vaccine Market, based on region, has been divided into the APAC & Middle East, Europe, Americas, and Africa.

The APAC & Middle East is likely to dominate the global avian influenza vaccine market. This can be attributed to the increasing production of poultry birds and the rise in avian influenza outbreaks in the region. According to a recent report from the Foreign Agricultural Service/USDA, China recorded 13,800 thousand metric tons of chicken meat production in 2019. Furthermore, various government initiatives for rapid and effective response efforts to emergent zoonotic influenza viruses are also expected to drive market growth.

The European market for the avian influenza vaccine is estimated to be the second-largest during the review period. The growing dependence on poultry as the key source of protein in the diet in this region is expected to boost the growth of the regional market. According to the European Commission, the European Union (EU) produced 15.2 million tons of poultry meat in 2018. Additionally, increasing the production of veterinary products and improved animal husbandry practices in Germany and Poland are further fueling market growth.

Americas is estimated to demonstrate significant market growth owing to the growing meat & poultry industry, the increasing expenditure on animal health, and the presence of a large number of veterinary hospitals in the region. According to the North American Meat Institute, the US exported 3.7 million metric tons (MT) of poultry and poultry variety meats in 2017. The value was estimated at USD 4.5 billion. Moreover, growing government support for creating awareness on avian influenza viruses and improving efficiency for the avian influenza vaccine is also positively affecting the market growth.

Key Players

The Prominent Players in the Global Avian Influenza Vaccine Market are Boehringer Ingelheim International GmbH (Germany), Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China), Ceva (US), Yebio Bioengineering Co., Ltd (China), Zoetis (US), FATRO S.P.A. (Italy), CAVAC (South Korea), Tianjin Ringpu Bio-Technology Co., Ltd (China), PT Japfa Comfeed Indonesia Tbk (Indonesia), Chengdu Tech-bank Biological Products Co., Ltd (China), Merck Animal Health (US), Medion (Indonesia), Avimex Animal Health (Mexico), JOVAC (Jordan), and QYH BIOTECH COMPANY LIMITED (China). Some of the key strategies followed by players operating in the global avian influenza vaccine market were collaborations, acquisition, product approval & launch, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/avian-influenza-vaccine-market-8769